Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Apr 1;32(4):353-358.
doi: 10.1097/GME.0000000000002496.

Efficacy and safety of Matricaria chamomilla intervention in managing menopausal symptoms: a triple-blind clinical trial

Affiliations
Randomized Controlled Trial

Efficacy and safety of Matricaria chamomilla intervention in managing menopausal symptoms: a triple-blind clinical trial

Farideh Mohsenzadeh-Ledari et al. Menopause. .

Abstract

Objective: Menopausal symptoms can significantly impact women's quality of life. Herbal interventions like Matricaria chamomilla (chamomile) have been suggested as potential remedies. However, their efficacy and safety remain underexplored.

Methods: This triple-blind clinical trial enrolled 80 postmenopausal women meeting specific criteria. Inclusion criteria included participants in early or late perimenopause, defined by a symptom score >15, FSH levels >40, or 2 years since menopause, with no significant comorbidities. Participants were randomly assigned to intervention and placebo groups. In a triple-blind clinical trial with 80 postmenopausal women (aged 47-62) from Babol City Health Center, participants were randomly assigned to receive either chamomile (100 mg capsules with 1.2% apigenin, four times daily) or a placebo over 12 weeks. Symptoms of menopause were assessed using the Australian Menopause Association's Scorecard Symptom Questionnaire. Over 12 weeks, they received either chamomile or placebo capsules, with side effect assessments every 4 weeks.

Results: Notable differences were found between the intervention and control groups in the overall scores on the symptom scorecard from baseline to 12 weeks' postintervention (-10.36; 95% confidence interval [CI], -13.84 to -6.92; P < 0.001). Specific subscores also improved in the intervention group: vasomotor (-2.25; 95% CI, -3.09 to -1.42; P < 0.001), psychological (-3.74; 95% CI, -5.29 to -2.20; P < 0.001), locomotor (-2.70; 95% CI, -3.63 to -1.77; P < 0.001), and urological (-1.89; 95% CI, -2.77 to -1.00; P < 0.001). Both groups showed significant changes in total symptom scores over time ( P < 0.001). Two participants experienced side effects, including mouth sores, skin spots, and itching, in the chamomile group, which led to their dropping out of the study.

Conclusions: Chamomile intervention shows promise in alleviating menopausal symptoms, but its use warrants caution due to associated side effects. Further research is necessary to optimize dosage and mitigate adverse reactions for safer and more effective management of menopausal symptoms.

PubMed Disclaimer

Conflict of interest statement

Financial disclosure/conflicts of interest: None reported.

References

    1. Shayan A, Masoumi SZ, Kazemi F, Oshvandi K. Effect of combined herbal capsule menohelp on hot flashes and night sweats in postmenopausal women: a single-blind randomized controlled trial. J Menopausal Med 2020;26:135–142. doi: 10.6118/jmm.20002 - DOI
    1. Saei Ghare Naz M, Sayehmiri F, Kiani F, Ozgoli G. A systematic review and meta-analysis on the average age of menopause among Iranian women. Evidence Based Care 2019;8:26–34. doi: 10.22038/ebcj.2018.32369.1820 - DOI
    1. Delavar MA, Hajiahmadi M. Factors affecting the age in normal menopause and frequency of menopausal symptoms in Northern Iran. Iran Red Crescent Med J 2011;13:192–198.
    1. Bansal R, Aggarwal N. Menopausal hot flashes: a concise review. J Midlife Health 2019;10:6–13. doi: 10.4103/jmh.JMH_7_19 - DOI
    1. Pacello P, Baccaro LF, Pedro AO, Costa-Paiva L. Prevalence of hormone therapy, factors associated with its use, and knowledge about menopause: a population-based household survey. Menopause 2018;25:683–690. doi: 10.1097/gme.0000000000001066 - DOI

Publication types

LinkOut - more resources